The Fulbright Program is the premier international educational exchange initiative of the United States of America, operating in collaboration with over 160 countries. It offers programs for distinguished scientists, artists, educators, and students.
The Fulbright Visiting Scholar Program is designed for faculty members at universities and research institutions, who are invited to teach and/or conduct research in the U.S. for a period of 3 to 6 months, following an official invitation from a host institution. Fewer than 10 faculty members across all disciplines are selected each year by Fulbright Greece and the U.S. Department of State to receive this prestigious fellowship.
Antonios Chatzigeorgiou, Associate Professor of Physiology at the Medical School of the National and Kapodistrian University of Athens (NKUA), has been selected as a Fulbright Visiting Scholar for 2025–2026 in the field of Life / Health Sciences. During the spring semester of the 2025–2026 academic year, Dr. Chatzigeorgiou will conduct research at the UMass Chan Medical School at the University of Massachusetts, in collaboration with Professor Alan Mullen, Academic Director of the Division of Gastroenterology and Mary C. DeFeudis Chair in Biomedical Research. Their project is titled: “Exploring Novel Therapeutic Approaches Against Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and Liver Fibrosis Utilizing Human Liver Organoids.”
UMass Chan Medical School is a world-renowned research institution that continuously produces significant advancements in both clinical and basic research and has been home to two Nobel Prize winners. This distinction represents a major success for the NKUA Medical School and constitutes an active channel of collaboration between the two Medical Schools (NKUA and UMass Chan) at both the research and educational levels.
Related links:
https://physiology.med.uoa.gr/
https://www.umassmed.edu/mullenlab/people/
